发明名称 GENE REGULATION
摘要 The present invention relates to peptides, which impair PBX-dependent regulation of gene transcription and thus have utility in the treatment or prevention of disorders in which aberrant cell division occurs. In particular, the invention provides peptides comprising the amino acid sequence (I), Y<SUB>1</SUB> X<SUB>1</SUB> X<SUB>2</SUB>X<SUB>3</SUB> W X<SUB>4</SUB> X<SUB>5</SUB> X<SUB>6</SUB>X<SUB>7</SUB>X<SUB>8</SUB> Y<SUB>2</SUB> (I) wherein the sequence X<SUB>1</SUB> to X<SUB>8</SUB> is an amino acid sequence comprising at least 8 amino acids, which may optionally be interrupted by one or two amino acid residues between one or more of the 9 amino acid positions defined herein; X<SUB>1</SUB> is selected from W, T, PE, KQI, VV, PQT, H, RI and absent; X<SUB>2</SUB> is an amino acid with an aromatic side chain or cysteine; X<SUB>3</SUB> is P or D; X<SUB>4</SUB> is a hydrophobic amino acid X<SUB>5</SUB> is an amino acid with a charged side chain; X<SUB>6</SUB> is an amino acid with a basic side chain; X<SUB>7</SUB> is a polar hydrophilic amino acid; X<SUB>8</SUB> is one or more amino acids or absent; and Y<SUB>1</SUB> and Y<SUB>2</SUB> are each either absent or a peptide comprising a cationic polymer of basic amino acids, such that at least one Of Y<SUB>1</SUB> and Y<SUB>2</SUB> is present; and peptides comprising the amino acid sequence (II): Y<SUB>3</SUB> X<SUB>1</SUB> X<SUB>2</SUB> X<SUB>3</SUB> W X<SUB>4</SUB> X<SUB>5</SUB> X<SUB>6</SUB> X<SUB>7</SUB> X<SUB>8</SUB> Y4 (II) wherein The sequence X<SUB>1</SUB> to X<SUB>8</SUB> is an amino acid sequence comprising at least 8 amino acids, which may optionally be interrupted by one or two amino acid residues between one or more of the 9 amino acid positions defined herein; X<SUB>1</SUB> is selected from W, T, PE, KQI, VV, PQT, H, RI and absent; X<SUB>2</SUB> is an amino acid with an aromatic side chain; X3 is P or D; X<SUB>4</SUB> is a hydrophobic amino acid X<SUB>5</SUB> is an amino acid with a charged side chain; X<SUB>6</SUB> is an amino acid with a basic side chain; X<SUB>7</SUB> is a polar hydrophilic amino acid; X<SUB>8</SUB> is one or more amino acids or absent; and Y<SUB>3</SUB> and Y<SUB>4</SUB> are each either absent or a peptide comprising a sequence comprising a cell penetration moiety, such that at least one of Y<SUB>3</SUB> and Y<SUB>4</SUB> is present; wherein at least the N-terminal and C-terminal amino acids of said peptide is in the D-conformation.
申请公布号 WO2007000601(A8) 申请公布日期 2008.03.27
申请号 WO2006GB02390 申请日期 2006.06.28
申请人 ST GEORGES ENTERPRISES LIMITED;MORGAN, RICHARD, GEORGE, LEONARD;SOHAL, JASTINDER 发明人 MORGAN, RICHARD, GEORGE, LEONARD;SOHAL, JASTINDER
分类号 A61K38/03;A61K38/04;A61K38/16;A61P35/00 主分类号 A61K38/03
代理机构 代理人
主权项
地址